{"id":1811,"date":"2020-06-15T19:15:33","date_gmt":"2020-06-15T19:15:33","guid":{"rendered":"https:\/\/magazines.uthscsa.edu\/cancer-center\/?p=1811"},"modified":"2020-06-16T21:11:11","modified_gmt":"2020-06-16T21:11:11","slug":"research-focused-on-improving-lymphoma-treatments-for-hispanics","status":"publish","type":"post","link":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/","title":{"rendered":"Research focused on improving lymphoma treatments for Hispanics"},"content":{"rendered":"

It\u2019s widely believed that Caucasians get better results from cancer treatments than Hispanics. But a study of Hodgkin\u2019s lymphoma patients conducted by Enrique Diaz, M.D., director of the Lymphoma Program at the Mays Cancer Center, dispels that notion.<\/p>\n

\"Enrique
Enrique Diaz, M.D., is studying Hodgkin\u2019s lymphoma with the goal of improving treatments for Hispanic patients.<\/figcaption><\/figure>\n

Lymphomas are cancers that start in white blood cells called lymphocytes, and the two main types are Hodgkin\u2019s lymphoma and non-Hodgkin\u2019s lymphoma.<\/p>\n

Of the Hodgkin\u2019s lymphoma patients treated at the Mays Cancer Center, \u201cHispanics tended to do about the same if not better than non-Hispanics with no statistically significant difference in outcome,\u201d Dr. Diaz says.<\/p>\n

His research analyzed a total of 616 patients, ultimately identifying 116 Hodgkin\u2019s lymphoma patients for inclusion. The study looked at the group over 10 years, beginning in 2008 and concluding in 2018. Of the patients, 63 percent were Hispanic, 36 percent were non-Hispanic, and 1 percent had an unspecified ethnicity. The average age was 37.4 years, and the largest percentage were diagnosed Stage II, although all cancer stages were represented. Men made up 58 percent of the group studied.<\/p>\n

Dr. Diaz says he was shocked by the results since, historically, Caucasians are seen to have a more positive outcome after a lymphoma cancer diagnosis than Hispanics, African Americans and Pacific Islanders. The survey is the largest study of Hodgkin\u2019s lymphoma patients from a single academic institution that primarily serves Hispanics.<\/p>\n

His interest in conducting the study was spurred by the lack of information comparing the outcomes of Hispanic patients with lymphoma with those of Caucasians, African Americans and other ethnicities with lymphoma, he says.<\/p>\n

The study also looked at survival outcome rates between lymphoma patients who have private insurance or Medicare versus those who are uninsured, on Medicaid or use a hospital payment plan available at the Mays Cancer Center.<\/p>\n

With 477 patients in the overall study, 47 percent had commercial insurance, 24 percent had Medicare, 18 percent were approved for indigent care coverage, 4 percent had Medicaid, and 7 percent were unfunded.<\/p>\n

\u201cWe were under the assumption that those patients lacking insurance would not do as well as those with a health policy in place,\u201d Dr. Diaz says.<\/p>\n

Again, to his surprise, the study found there was no significant vitality difference between patients with private insurance or Medicare versus those who were unfunded or had Medicaid or indigent care coverage.<\/p>\n

\u201cEven with the challenges of a lack of health insurance, those patients did about the same (as insured patients),\u201d he says.<\/p>\n

Dr. Diaz can\u2019t be sure of the reason, theorizing that it may be the quality of care that the Mays Cancer Center provides all its cancer patients, the fact that the center has a hospital payment plan which helps the uninsured, or possible differences in biology.<\/p>\n

\u201cIt\u2019s quite shocking,\u201d he says of the findings that demonstrated that regardless of the type of lymphoma there was no difference in longevity whether or not patients had insurance.
\nThe study also looked at the effect co-morbidities have on lymphoma patients at the center, again comparing Hispanic and non-Hispanic populations. The thinking was that the simultaneous presence of more than one disease would negatively impact treatment decisions and outcomes.<\/p>\n

The study identified 477 patients with both Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma. Males made up 51 percent of the population; 55 percent were Hispanic, 43 percent were non-Hispanic, and 2 percent were not specified.<\/p>\n

Of the co-morbidities \u2014 hypertension, diabetes, chronic kidney disease, coronary artery disease and congestive heart failure \u2014 looked at in these 477 patients, the combination of congestive heart failure and coronary artery disease had the most negative impact on patient outcome. The study showed that in the prominently Hispanic population the center serves, co-morbidities increased the risk of a poor cancer outcome. There was a higher risk for negative outcomes in the non-Hispanic population than in the Hispanic group, though further studies are needed.<\/p>\n

Hispanics have historically been underrepresented in studies, says Dr. Diaz, who presented his findings at the annual meeting of the American Society of Hematology in late 2019 in Orlando, Florida.<\/p>\n

Dr. Diaz, who completed his medical training with honors at the Pontificia Universidad Javeriana in Colombia and his internal medicine residency at New York University, worked on the study for two years. His research focuses on both improving cancer outcomes in his lymphoma patients and on disparities in health care.<\/p>\n

Currently serving as Ambassador for the American Society of Hematology, Dr. Diaz plans to do future studies with a larger population sample over a longer time frame, possibly 20 years.
\nDr. Diaz said the specialty has particular appeal to him because of the often-positive outcomes in lymphoma patients.<\/p>\n

\u201cI get to deliver good news,\u201d he says. \u201cI like that.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

Enrique Diaz, M.D., director of the Lymphoma Program at the Mays Cancer Center, discovered that Hispanic Hodgkin\u2019s lymphoma patients experience the same or better results from cancer treatment as Caucasian patients. <\/p>\n","protected":false},"author":43,"featured_media":1867,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"magazine":[22],"issue-year":[44],"featured-story":[],"class_list":["post-1811","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research","magazine-cancer-center","issue-year-44"],"yoast_head":"\nResearch focused on improving lymphoma treatments for Hispanics - Mays Cancer Center Annual Report<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Research focused on improving lymphoma treatments for Hispanics - Mays Cancer Center Annual Report\" \/>\n<meta property=\"og:description\" content=\"Enrique Diaz, M.D., director of the Lymphoma Program at the Mays Cancer Center, discovered that Hispanic Hodgkin\u2019s lymphoma patients experience the same or better results from cancer treatment as Caucasian patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/\" \/>\n<meta property=\"og:site_name\" content=\"Mays Cancer Center Annual Report\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-15T19:15:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-16T21:11:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2020\/06\/DiazE_featured.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"480\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"duncancl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"duncancl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/\"},\"author\":{\"name\":\"duncancl\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/#\\\/schema\\\/person\\\/92ba77ef72a0095914424aa87b09c99c\"},\"headline\":\"Research focused on improving lymphoma treatments for Hispanics\",\"datePublished\":\"2020-06-15T19:15:33+00:00\",\"dateModified\":\"2020-06-16T21:11:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/\"},\"wordCount\":795,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2020\\\/06\\\/DiazE_featured.jpg\",\"articleSection\":[\"Research\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/\",\"name\":\"Research focused on improving lymphoma treatments for Hispanics - Mays Cancer Center Annual Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2020\\\/06\\\/DiazE_featured.jpg\",\"datePublished\":\"2020-06-15T19:15:33+00:00\",\"dateModified\":\"2020-06-16T21:11:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/#\\\/schema\\\/person\\\/92ba77ef72a0095914424aa87b09c99c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2020\\\/06\\\/DiazE_featured.jpg\",\"contentUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2020\\\/06\\\/DiazE_featured.jpg\",\"width\":800,\"height\":480,\"caption\":\"Enrique Diaz, M.D.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2020\\\/06\\\/15\\\/research-focused-on-improving-lymphoma-treatments-for-hispanics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mays Cancer Center Annual Report\",\"item\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/magazine\\\/cancer-center\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Research focused on improving lymphoma treatments for Hispanics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/#website\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/\",\"name\":\"Mays Cancer Center Annual Report\",\"description\":\"Mays Cancer Center Annual Reports\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/#\\\/schema\\\/person\\\/92ba77ef72a0095914424aa87b09c99c\",\"name\":\"duncancl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4561cd958c8f1ae172cfa6e6a22ea689cad8a0153177b8c4b0997fa83e7bbe33?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4561cd958c8f1ae172cfa6e6a22ea689cad8a0153177b8c4b0997fa83e7bbe33?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4561cd958c8f1ae172cfa6e6a22ea689cad8a0153177b8c4b0997fa83e7bbe33?s=96&d=mm&r=g\",\"caption\":\"duncancl\"},\"description\":\"Catherine Duncan is director of communications for the Office of Institutional Advancement. She also serves as editor and publications director for Salute magazine.\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/author\\\/duncancl\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Research focused on improving lymphoma treatments for Hispanics - Mays Cancer Center Annual Report","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/","og_locale":"en_US","og_type":"article","og_title":"Research focused on improving lymphoma treatments for Hispanics - Mays Cancer Center Annual Report","og_description":"Enrique Diaz, M.D., director of the Lymphoma Program at the Mays Cancer Center, discovered that Hispanic Hodgkin\u2019s lymphoma patients experience the same or better results from cancer treatment as Caucasian patients.","og_url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/","og_site_name":"Mays Cancer Center Annual Report","article_published_time":"2020-06-15T19:15:33+00:00","article_modified_time":"2020-06-16T21:11:11+00:00","og_image":[{"width":800,"height":480,"url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2020\/06\/DiazE_featured.jpg","type":"image\/jpeg"}],"author":"duncancl","twitter_card":"summary_large_image","twitter_misc":{"Written by":"duncancl","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/#article","isPartOf":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/"},"author":{"name":"duncancl","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/#\/schema\/person\/92ba77ef72a0095914424aa87b09c99c"},"headline":"Research focused on improving lymphoma treatments for Hispanics","datePublished":"2020-06-15T19:15:33+00:00","dateModified":"2020-06-16T21:11:11+00:00","mainEntityOfPage":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/"},"wordCount":795,"commentCount":0,"image":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/#primaryimage"},"thumbnailUrl":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2020\/06\/DiazE_featured.jpg","articleSection":["Research"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/","url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/","name":"Research focused on improving lymphoma treatments for Hispanics - Mays Cancer Center Annual Report","isPartOf":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/#website"},"primaryImageOfPage":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/#primaryimage"},"image":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/#primaryimage"},"thumbnailUrl":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2020\/06\/DiazE_featured.jpg","datePublished":"2020-06-15T19:15:33+00:00","dateModified":"2020-06-16T21:11:11+00:00","author":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/#\/schema\/person\/92ba77ef72a0095914424aa87b09c99c"},"breadcrumb":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/#primaryimage","url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2020\/06\/DiazE_featured.jpg","contentUrl":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2020\/06\/DiazE_featured.jpg","width":800,"height":480,"caption":"Enrique Diaz, M.D."},{"@type":"BreadcrumbList","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2020\/06\/15\/research-focused-on-improving-lymphoma-treatments-for-hispanics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/magazines.uthscsa.edu\/cancer-center\/"},{"@type":"ListItem","position":2,"name":"Mays Cancer Center Annual Report","item":"https:\/\/magazines.uthscsa.edu\/cancer-center\/magazine\/cancer-center\/"},{"@type":"ListItem","position":3,"name":"Research focused on improving lymphoma treatments for Hispanics"}]},{"@type":"WebSite","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/#website","url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/","name":"Mays Cancer Center Annual Report","description":"Mays Cancer Center Annual Reports","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/magazines.uthscsa.edu\/cancer-center\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/#\/schema\/person\/92ba77ef72a0095914424aa87b09c99c","name":"duncancl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4561cd958c8f1ae172cfa6e6a22ea689cad8a0153177b8c4b0997fa83e7bbe33?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4561cd958c8f1ae172cfa6e6a22ea689cad8a0153177b8c4b0997fa83e7bbe33?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4561cd958c8f1ae172cfa6e6a22ea689cad8a0153177b8c4b0997fa83e7bbe33?s=96&d=mm&r=g","caption":"duncancl"},"description":"Catherine Duncan is director of communications for the Office of Institutional Advancement. She also serves as editor and publications director for Salute magazine.","url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/author\/duncancl\/"}]}},"_links":{"self":[{"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/posts\/1811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/comments?post=1811"}],"version-history":[{"count":0,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/posts\/1811\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/media\/1867"}],"wp:attachment":[{"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/media?parent=1811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/categories?post=1811"},{"taxonomy":"magazine","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/magazine?post=1811"},{"taxonomy":"issue-year","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/issue-year?post=1811"},{"taxonomy":"featured-story","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/featured-story?post=1811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}